These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21168135)

  • 41. Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
    Terpos E; Heath DJ; Rahemtulla A; Zervas K; Chantry A; Anagnostopoulos A; Pouli A; Katodritou E; Verrou E; Vervessou EC; Dimopoulos MA; Croucher PI
    Br J Haematol; 2006 Dec; 135(5):688-92. PubMed ID: 17107351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of serum TRACP in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Yam LT
    J Bone Miner Res; 2008 Aug; 23(8):1287-95. PubMed ID: 18410226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement.
    Landgraeber S; Löer F; Heep H; Classen T; Grabellus F; Totsch M; von Knoch M
    Arch Orthop Trauma Surg; 2010 Apr; 130(4):441-5. PubMed ID: 19513735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of bone turnover markers and serum minerals variations for predicting fracture healing versus non-union processes in adult sheep as a model for orthopedic research.
    Sousa CP; Lopez-Peña M; Guzón FM; Abreu HV; Luís MR; Viegas CA; Camassa J; Azevedo JT; Cabrita AS; Reis RL; Gomes ME; Dias IR
    Injury; 2017 Aug; 48(8):1768-1775. PubMed ID: 28601248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ; Lederer ED; Price BA; Yam LT
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship among bone mineral density, collagen composition, and biomechanical properties of callus in the healing of osteoporotic fracture.
    Shen B; Mu JX; Pei FX
    Chin J Traumatol; 2007 Dec; 10(6):360-5. PubMed ID: 18045519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
    Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
    J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study.
    Schulze-Späte U; Turner R; Wang Y; Chao R; Schulze PC; Phipps K; Orwoll E; Dam TT
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2425-33. PubMed ID: 25856210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An in vitro model for discovery of osteoclast specific biomarkers towards identification of racehorses at risk for catastrophic fractures.
    Malek G; Richard H; Beauchamp G; Laverty S
    Equine Vet J; 2023 May; 55(3):534-550. PubMed ID: 35616632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab].
    Tatekoshi A; Sato T; Ibata S; Hashimoto A; Kamihara Y; Horiguchi H; Ono K; Takada K; Iyama S; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2014 Nov; 55(11):2271-6. PubMed ID: 25501406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
    Fahrleitner-Pammer A; Piswanger-Soelkner JC; Pieber TR; Obermayer-Pietsch BM; Pilz S; Dimai HP; Prenner G; Tscheliessnigg KH; Hauge E; Portugaller RH; Dobnig H
    J Bone Miner Res; 2009 Jul; 24(7):1335-44. PubMed ID: 19257824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
    Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone Metabolism in the Healing Process of Lumbar Interbody Fusion: Temporal Changes of Bone Turnover Markers.
    Hyakkan R; Kanayama M; Takahata M; Oha F; Hashimoto T; Iwasaki N
    Spine (Phila Pa 1976); 2021 Dec; 46(23):1645-1652. PubMed ID: 33882539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics of bone turnover markers in rapidly destructive coxopathy.
    Abe H; Sakai T; Ogawa T; Takao M; Nishii T; Nakamura N; Sugano N
    J Bone Miner Metab; 2017 Jul; 35(4):412-418. PubMed ID: 27550182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
    Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
    Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in biochemical markers after lower limb fractures.
    Stoffel K; Engler H; Kuster M; Riesen W
    Clin Chem; 2007 Jan; 53(1):131-4. PubMed ID: 17130179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.